Raymond James Financial Services Advisors’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,400
| Closed | -$8K | – | 2775 |
|
|
2020
Q1 | $8K | Sell |
1,400
-7
| -0.5% | -$40 | ﹤0.01% | 2378 |
|
|
2019
Q4 | $9K | Buy |
1,407
+834
| +146% | +$5.34K | ﹤0.01% | 2803 |
|
|
2019
Q3 | $4K | Hold |
573
| – | – | ﹤0.01% | 2758 |
|
|
2019
Q2 | $4K | Hold |
573
| – | – | ﹤0.01% | 2794 |
|
|
2019
Q1 | $8K | Hold |
573
| – | – | ﹤0.01% | 2747 |
|
|
2018
Q4 | $7K | Hold |
573
| – | – | ﹤0.01% | 2534 |
|
|
2018
Q3 | $13K | Hold |
573
| – | – | ﹤0.01% | 2758 |
|
|
2018
Q2 | $11K | Hold |
573
| – | – | ﹤0.01% | 2724 |
|
|
2018
Q1 | $6K | Sell |
573
-267
| -32% | -$2.8K | ﹤0.01% | 2508 |
|
|
2017
Q4 | $17K | Buy |
840
+233
| +38% | +$4.72K | ﹤0.01% | 2472 |
|
|
2017
Q3 | $10K | Hold |
607
| – | – | ﹤0.01% | 2510 |
|
|
2017
Q2 | $22K | Hold |
607
| – | – | ﹤0.01% | 2431 |
|
|
2017
Q1 | $27K | Buy |
607
+34
| +6% | +$1.51K | ﹤0.01% | 2328 |
|
|
2016
Q4 | $15K | Hold |
573
| – | – | ﹤0.01% | 2288 |
|
|
2016
Q3 | $23K | Hold |
573
| – | – | ﹤0.01% | 2220 |
|
|
2016
Q2 | $30K | Buy |
573
+6
| +1% | +$314 | ﹤0.01% | 2174 |
|
|
2016
Q1 | $34K | Buy |
+567
| New | +$34K | ﹤0.01% | 1967 |
|